Active	Status	Sponsor type	Region	Phase	Filter
1 Active 7 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Novak, John
REFINE-ALS, NCT04259255: Radicava® (Edaravone) Findings in Biomarkers From ALS	Active, not recruiting	N/A	300	Canada, US	Edaravone (Radicava®/Radicava ORS®), Radicava®, Radicava ORS®	Mitsubishi Tanabe Pharma America Inc., Massachusetts General Hospital	Amyotrophic Lateral Sclerosis, ALS	03/24	03/24